Payer

The funds come two years after the company scored a $1.15 billion investment.

The pharma giant will also pay $55 million to fund the point-of-care diagnostics platform until the acquisition closes, which is expected to occur by mid-2024.

Digital health leaders say frameworks already exist that can be adopted for AI regulation, but going too far with rules could stifle innovation.

From the end of the Public Health Emergency to the launch of ChatGPT and the Apple Vision Pro, executives reflect on what stood out to them this year.

Thomas Hallisey, HANYS digital health strategy lead, discusses appropriate regulations on digital health at the state and federal levels and the need for continuous management as technology moves from automating healthcare to augmenting it.  

AI is a tool to help people everywhere realize their health potential, said HIMSS Chief Scientific Research Officer Anne Snowden. If there was a time for learning, sharing and building a community of AI decision-making tools, it is now.  

Steven Ullman, the University of Miami's director at the Center for Health Management and Policy, discusses telehealth use during and following the pandemic, why patient and provider satisfaction varies, and policy predictions for 2024.  

As host of HIMSS AI in Healthcare Forum, Robert Havasy, senior director of the Personal Connected Health Alliance at HIMSS, discusses the cautious optimism and warnings he heard from speakers and attendees about AI technology and its progress.  

Healthcare organizations and technology companies must work together to ensure responsible and ethical AI use and to explore the true benefits of AI.

The two models of MedLM are built on the tech giant's medical LLM Med-PaLM 2, with one designed for complex tasks and the other for scaling across various tasks.